scholarly article | Q13442814 |
P2093 | author name string | Debra Skinner | |
Martha King | |||
Kelly A Raspberry | |||
P2860 | cites work | Evolving approaches to the ethical management of genomic data | Q24618993 |
Recommendations for returning genomic incidental findings? We need to talk! | Q26995124 | ||
ClinGen--the Clinical Genome Resource | Q28648173 | ||
Guidelines for investigating causality of sequence variants in human disease | Q28655218 | ||
Characterizing genetic variants for clinical action | Q28655937 | ||
ACMG clinical laboratory standards for next-generation sequencing | Q33903280 | ||
Translating personalized medicine using new genetic technologies in clinical practice: the ethical issues | Q34159801 | ||
Negotiating desires and options: how mothers who carry the fragile X gene experience reproductive decisions | Q34762304 | ||
Clinical exome sequencing for genetic identification of rare Mendelian disorders | Q34782655 | ||
Molecular findings among patients referred for clinical whole-exome sequencing | Q35078373 | ||
Flexible positions, managed hopes: the promissory bioeconomy of a whole genome sequencing cancer study | Q35187045 | ||
Point-counterpoint. Patient autonomy and incidental findings in clinical genomics | Q37040336 | ||
ClinVar: public archive of relationships among sequence variation and human phenotype | Q37661886 | ||
Clinical exome sequencing in daily practice: 1,000 patients and beyond | Q37689764 | ||
Parental beliefs about cause and course of their child's autism and outcomes of their beliefs: a review of the literature | Q37774654 | ||
The sociology of medical screening: past, present and future | Q37988596 | ||
The chromosome 22q11.2 deletion: from the unification of biomedical fields to a new kind of genetic condition | Q38032624 | ||
Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. | Q38037294 | ||
Informatics and clinical genome sequencing: opening the black box. | Q38043287 | ||
Diagnostic clinical genome and exome sequencing | Q38221192 | ||
Managing the ethical challenges of next-generation sequencing in genomic medicine | Q38239811 | ||
Expanded newborn screening: articulating the ontology of diseases with bridging work in the clinic | Q38500677 | ||
Who's to blame? Accounts of genetic responsibility and blame among Ashkenazi Jewish women at risk of BRCA breast cancer. | Q39662596 | ||
Experiencing the genetic body: parents' encounters with pediatric clinical genetics | Q40162824 | ||
Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. | Q40510267 | ||
Kinscapes, timescapes and genescapes: families living with genetic risk | Q45788612 | ||
Towards a sociology of diagnosis: reflections and opportunities | Q48605146 | ||
Trust in standards: transitioning clinical exome sequencing from bench to bedside. | Q53567206 | ||
Eclipse of the Gene and the Return of Divination | Q57632742 | ||
Genome-scale sequencing in clinical care: establishing molecular diagnoses and measuring value | Q64049894 | ||
Regulating diagnosis in post-genomic medicine: re-aligning clinical judgment? | Q64953912 | ||
Diagnosis, dysmorphology, and the family: knowledge, motility, choice | Q80238114 | ||
Making genetics not so important: family work in dealing with familial hypertrophic cardiomyopathy | Q84568300 | ||
Constructing Grounded Theory: A practical guide through qualitative analysis | Q88480597 | ||
P433 | issue | 8 | |
P304 | page(s) | 1303-1317 | |
P577 | publication date | 2016-08-19 | |
P1433 | published in | Sociology of Health and Illness | Q7552840 |
P1476 | title | The nuanced negative: Meanings of a negative diagnostic result in clinical exome sequencing | |
P478 | volume | 38 |
Q55089341 | "Possibly positive or certainly uncertain?": participants' responses to uncertain diagnostic results from exome sequencing. |
Q38754326 | "Set in Stone" or "Ray of Hope": Parents' Beliefs About Cause and Prognosis After Genomic Testing of Children Diagnosed with ASD. |
Q55074639 | Clinical providers' experiences with returning results from genomic sequencing: an interview study. |
Q92380881 | Development and mixed-methods evaluation of an online animation for young people about genome sequencing |
Q47278375 | Diagnostic exome sequencing in children: A survey of parental understanding, experience and psychological impact |
Q90679190 | Diagnostic utility of transcriptome sequencing for rare Mendelian diseases |
Q38993360 | Expert Knowledge Influences Decision-Making for Couples Receiving Positive Prenatal Chromosomal Microarray Testing Results. |
Q91937762 | Genomic knowledge in the context of diagnostic exome sequencing: changes over time, persistent subgroup differences, and associations with psychological sequencing outcomes |
Q41686977 | How do providers discuss the results of pediatric exome sequencing with families? |
Q92133078 | Parents' perceptions of personal utility of exome sequencing results |
Q97569110 | Patient reactions to receiving negative genomic screening results by mail |
Q47664781 | Psychosocial Profiles of Parents of Children with Undiagnosed Diseases: Managing Well or Just Managing? |
Q57163463 | Return of individual results in epilepsy genomic research: A view from the field |
Q57178162 | Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies |
Q49933290 | The Actionability of Exome sequencing testing results |
Search more.